United States: Making Sense Of MACRA

Bracing for the Medicare Part B Overhaul: Pick a Path, Pick a Pace

The countdown has begun for the momentous Part B payment reforms created by the Medicare Access and Chip Reauthorization Act of 2015 (MACRA). On October 14, 2016, CMS released a final rule explaining, in nearly 2,400 pages, how its new Quality Payment Program, established under MACRA, will work when the first performance period goes live on January 1, 2017.

Through MACRA, Congress finally compromised and repealed the much-maligned sustainable growth rate (SGR) formula for Part B payments. While this aspect of the "doc fix" bill was widely publicized and easily understood, the other details of MACRA still remain a mystery to many. Recent surveys reveal that as of September, almost 30 percent of physicians had not even heard of MACRA, down from 50 percent in July.

The complexities of MACRA's massive overhaul of Part B pose challenges to clinicians seeking to understand and prepare for its implementation. This concern was a common theme in the more than 4,000 comments CMS received on its proposed rule. CMS responded by outlining a staged approach to implementing MACRA reform in its final rule, calling CY 2017 (and perhaps CY 2018) a "transition year." But the agency's ultimate vision is ambitious and accelerates its transition to value-based accountable care.

Immediate Impacts: Out with the Old

The SGR is out, replaced by modest annual inflationary increases of 0.5 percent until 2019 and 0.25 percent starting in 2026. MACRA also sunsets three legacy quality reporting and performance programs: (1) the Physician Quality Reporting System (PQRS), (2) the Value-based Payment Modifier (VM) and (3) the Medicare EHR Incentive Program (commonly known as the "Meaningful Use" program). The legacy programs will officially end with their final payment adjustments in 2018 based on pre-sunset reporting periods.

In With the New: What is the Medicare Quality Payment Program?

The Medicare Quality Payment Program is not just a payment rule, it is a bold "milestone" effort to transform how care is delivered and to encourage Part B clinicians to transition from fee-for-service reimbursement to alternative payment models (APMs). The Quality Payment Program offers two paths: (1) the Merit-based Incentive Payment System (MIPS) and (2) Advanced Alternative Payment Models (Advanced APMs).

Through the Quality Payment Program, CMS is encouraging clinicians to accept risk for a defined episode of care or population through participation in the Advanced APMs with a 5 percent annual incentive payment. MIPS is the default pathway for clinicians who do not qualify to participate in an Advanced APM. Failure to participate in either an Advanced APM or the MIPS results in negative payment adjustments.

Who Must Participate?

Eligible clinicians include physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and groups that bill under Medicare Part B. Clinicians may elect to participate individually or as a group with a common tax identification number.

There are certain limited exclusions for:

  • Low Volume Clinicians: Clinicians with less than $30,000 in Medicare Part B allowed charges or 100 or fewer Medicare patients. CMS anticipates approximately 32.5 percent of eligible clinicians billing Part B services will qualify as low-volume clinicians in CY 2017.
  • New Medicare Enrolled Eligible Clinicians: New Medicare enrolled practitioners in their first year.

Picking a Path

Option 1:Advanced APMs

To participate in the Advanced APM pathway, clinicians must have a certain percentage of their patients or payments through an Advanced APM. The final rule describes the criteria for an APM to qualify as an Advanced APM.

  • As a threshold matter, the APM must be: an incentive model under Section 1115A of the Social Security Act (SSA), excluding a healthcare innovation award; the Shared Savings Program under Section 1899 of the SSA; or a demonstration under Section 1866 of the SSA, or a demonstration required by federal law.
  • Additionally, the APM must: (1) require participants to use certified electronic health record technology (CEHRT), (2) provide for payment for covered professional services based on quality measures comparable to those in the quality performance category under MIPS, and (3) either require that participating entities bear risk for monetary losses of more than a nominal amount under the APM, or be a Medical Home Model expanded under Section 1115A(c) of the SSA.

CMS is finalizing an initial set of Advanced APM determinations that will be released no later than January 1, 2017. CMS has already indicated the following APMs will qualify as Advanced APMs for CY 2017.

  • Comprehensive ESRD Care Model (Large Dialysis Organization (LDO) arrangement)
  • Comprehensive ESRD Care Model (non-LDO arrangement)
  • Comprehensive Primary Care Plus (CPC+)
  • Medicare Shared Savings Program ACOs - Track 2
  • Medicare Shared Savings Program ACOs - Track 3
  • Next Generation ACO Model
  • Oncology Care Model (two-sided risk arrangement)

CMS intends to change and grow this list as more APMs are proposed and developed in partnership with the clinician community and the Physician-Focused Payment Model Technical Advisory Committee. The agency anticipates (but has not formally confirmed) that the following APMs will qualify as Advanced APMs in CY 2018:

The final rule sets thresholds for the level of participation in Advanced APMs required for a Qualifying APM Participant (QP) for a year. Notably, the rule gives clinicians some credit for participation in non-Medicare APMs. CMS estimates that 5 to 8 percent of eligible clinicians will qualify for participation in Advanced APMs in CY 2017.

Option 2: MIPS

MIPS is the default pathway for eligible clinicians. CMS estimates that between 592,000 and 642,000 eligible clinicians will be required to participate in MIPS in CY 2017. But the agency anticipates that over time, an increasing number of clinicians will transition from MIPS into the Advanced APM pathway. Under MIPS, clinicians will receive payment adjustments based on data submitted in four categories: quality, improvement activities, advancing care information and cost. While the improvement activities category is new, the other categories contain elements of the legacy PQRS, VM and Meaningful Use programs.

While CY 2017 marks the first MIPS performance year, payments will not be impacted until CY 2019.

Physicians will receive a MIPS score of 1 to 100 and will be paid based on an adjusted scale. In calculating the score, CMS has weighted the categories. Notably, the cost metric will be phased in over time and is weighted at zero for the CY 2017 transition year.

Additionally, MIPS phases in both negative and positive payment adjustments over time.

CMS intends that MIPS negative and positive payment adjustments will be equally distributed to ensure budget neutrality and estimates each of the adjustments will be $199 million when payments are first made in 2019. Additionally, CMS will pay $500 million for exceptional performance payments to eligible clinicians whose MIPS score is at least 70.

Picking a Pace

Recognizing the complexity of the Quality Payment Program and the tight implementation timeline, CMS introduced a "Pick Your Pace" option for eligible clinicians under the MIPS that decreases the reporting timeframe and scope of data.

  • Minimum Reporting. To avoid the negative 4 percent payment adjustment, in CY 2017 clinicians can report one measure in the quality performance category; one activity in the improvement activities performance category; or report the required measures of the advancing care coordination performance category.
  • Medium Reporting for Part of CY. Clinicians can report for less than the full CY but at least a full 90-day period on more than one quality measure, improvement activity or required measure in the advancing care information performance category to both avoid the negative 4 percent payment adjustment and possibly receive a positive MIPS payment adjustment.
  • Full Reporting for Partial or Entire CY. Clinicians can fully report to MIPS for a 90-day performance period or the entire CY to avoid the negative 4 percent payment adjustment and enhance the possibility for positive MIPS payment adjustments.

Preparing for the Long Haul

Success under the Quality Payment Program will involve changes to technology, infrastructure, physician support systems and clinical practices. CMS is providing $100 million over the next five years in technical assistance to MIPS-eligible clinicians in small practices, rural areas and practices located in geographic health professional shortage areas (HPSAs) and is evaluating the impact of MACRA on solo and small physician practices.

Eligible clinicians, even those familiar with the legacy reporting programs, must adapt to a whole new system of reporting and scoring. The MACRA rule further incentivizes these clinicians to examine their readiness to participate in APMs and weigh potential incentives against possible downside risk.

To prepare for the impending Part B reform, hospitals and physician groups should evaluate their current employment and professional services arrangements to ensure incentives and practice patterns are aligned with rewards under the Quality Payment Program. And as eligible clinicians adapt to these changes, an examination of reimbursement under fee-for-service commercial contracts (that may reward volume) will be warranted to ensure clinicians are rewarded for achievements in delivering quality accountable care.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions